Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
Graphic: StemSmart Crohn's disease clinical trial, seven vials with six filled for the FDA questions answered favourably and one open for viral safety
  • Pharmaceuticals
2 hours ago2 hours ago

FDA Backs Proposed Stem Cell Trial for Treatment-Resistant Crohn’s Disease

StemSmart Crohn’s disease clinical trial gets positive FDA pre-IND feedback on 6 of 7 questions; a viral safety issue remains. Not a marketing approval.

  • Sun Pharma Board Caps Debenture Raise at ₹10,000 Crore
  • Tortugas’ Obuprazine Beats Placebo in Phase 2b Schizophrenia Study
  • Supreme Court Pushes Beyond Cancer Drugs on Medicine Prices
Graphic: at-home heart failure treatment study shown as a house with a cross beside an evidence ladder highlighting a single-arm study
  • Medical Devices
2 hours ago2 hours ago

Lasix ONYU Home Study: 18 of 21 Heart Failure Patients Avoided Admission

Early data say 18 of 21 heart failure patients were treated at home with Lasix ONYU. What hospital leaders can and cannot conclude from a single-arm study.

  • Castle Biosciences Data Show Barrett’s Risk Test Shifts Surveillance Plans
  • Envoy’s Fully Implanted Cochlear Implant Files Second FDA Module
  • Stryker Invests $400M in CMR Surgical: What the Deal Covers
Graphic: TissueCypher Barrett's esophagus test pathway from biopsy to risk class to management plan, with 83% low risk and 96% matched recommendations
  • Medical Devices
2 hours ago2 hours ago

Castle Biosciences Data Show Barrett’s Risk Test Shifts Surveillance Plans

Castle Biosciences says TissueCypher changed Barrett’s management for 96% of cohort patients. Where the test fits in surveillance and what is unproven.

  • Lasix ONYU Home Study: 18 of 21 Heart Failure Patients Avoided Admission
  • Envoy’s Fully Implanted Cochlear Implant Files Second FDA Module
  • Stryker Invests $400M in CMR Surgical: What the Deal Covers
Graphic: Envoy Medical Acclaim cochlear implant status checklist beside a cochlear spiral, with three milestones done and one pending
  • Medical Devices
3 hours ago2 hours ago

Envoy’s Fully Implanted Cochlear Implant Files Second FDA Module

Envoy Medical has filed 2 of 4 FDA modules for its investigational Acclaim implant. A status board of what is done, pending and still undisclosed.

  • Lasix ONYU Home Study: 18 of 21 Heart Failure Patients Avoided Admission
  • Castle Biosciences Data Show Barrett’s Risk Test Shifts Surveillance Plans
  • Stryker Invests $400M in CMR Surgical: What the Deal Covers
  • Industry Insights

Capnography Devices Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 2 hours ago2 hours ago
  • Industry Insights

Mastopexy Market Revenue, Trends, and Strategic Insights by 2035

Megan Wood 2 hours ago2 hours ago
Graphic: StemSmart Crohn's disease clinical trial, seven vials with six filled for the FDA questions answered favourably and one open for viral safety
  • Pharmaceuticals

FDA Backs Proposed Stem Cell Trial for Treatment-Resistant Crohn’s Disease

Megan Wood2 hours ago2 hours ago013 mins

StemSmart Crohn’s disease clinical trial gets positive FDA pre-IND feedback on 6 of 7 questions; a viral safety issue remains. Not a marketing approval.

Read More
Graphic: at-home heart failure treatment study shown as a house with a cross beside an evidence ladder highlighting a single-arm study
  • Medical Devices

Lasix ONYU Home Study: 18 of 21 Heart Failure Patients Avoided Admission

Megan Wood2 hours ago2 hours ago011 mins

Early data say 18 of 21 heart failure patients were treated at home with Lasix ONYU. What hospital leaders can and cannot conclude from a single-arm study.

Read More
Graphic: TissueCypher Barrett's esophagus test pathway from biopsy to risk class to management plan, with 83% low risk and 96% matched recommendations
  • Medical Devices

Castle Biosciences Data Show Barrett’s Risk Test Shifts Surveillance Plans

Megan Wood2 hours ago2 hours ago012 mins

Castle Biosciences says TissueCypher changed Barrett’s management for 96% of cohort patients. Where the test fits in surveillance and what is unproven.

Read More
Graphic: Envoy Medical Acclaim cochlear implant status checklist beside a cochlear spiral, with three milestones done and one pending
  • Medical Devices

Envoy’s Fully Implanted Cochlear Implant Files Second FDA Module

Megan Wood3 hours ago2 hours ago011 mins

Envoy Medical has filed 2 of 4 FDA modules for its investigational Acclaim implant. A status board of what is done, pending and still undisclosed.

Read More
Graphic: Sun Pharma ₹10,000 crore NCD issue shown as circles for tranches beside a rating badge
  • Pharmaceuticals

Sun Pharma Board Caps Debenture Raise at ₹10,000 Crore

Megan Wood3 hours ago2 hours ago012 mins

Sun Pharma will raise up to ₹10,000 crore via NCDs, down from ₹15,000 crore, as Gautam Doshi quits. NCD terms explained, ratings and open questions.

Read More
Graphic: obuprazine schizophrenia clinical trial, three capsule shapes for each dose range with placebo-adjusted PANSS changes
  • Pharmaceuticals

Tortugas’ Obuprazine Beats Placebo in Phase 2b Schizophrenia Study

Megan Wood3 hours ago2 hours ago011 mins

Tortugas reports obuprazine beat placebo at all doses in a 363-patient Phase 2b. Five claims checked against the evidence, plus what is still missing.

Read More
Graphic: medicine price control India 2026, supply chain from maker to patient with a 30% margin cap for cancer drugs only
  • Pharmaceuticals

Supreme Court Pushes Beyond Cancer Drugs on Medicine Prices

Megan Wood3 hours ago2 hours ago011 mins

Judges asked why India’s 30% cancer drug margin cap should not cover other medicines. What changes for makers, chemists, hospitals and patients.

Read More
Graphic: Stryker CMR Surgical investment shown as three rising steps, $400M investment, US sales rights and an option to buy
  • Medical Devices

Stryker Invests $400M in CMR Surgical: What the Deal Covers

Megan Wood5 hours ago2 hours ago011 mins

Stryker commits about $400M to CMR Surgical, gains US Versius sales rights and a buy-out option. Answers on terms, risks and what is still undisclosed.

Read More
Philips Lumify ultrasound FDA safety alert: four deaths and eight serious injuries reported with a timeline from 24 September to 9 October 2026
  • Medical Devices

FDA Early Alert: Philips Lumify Ultrasound Issue, Four Deaths Reported

Megan Wood8 hours ago2 hours ago012 mins

Philips Lumify ultrasound FDA safety alert: four deaths and eight serious injuries reported over two faults. What the FDA said and what users should do.

Read More
  • 1
  • 2
  • 3
  • …
  • 44

Categories

  • Healthcare IT (14)
  • Industry Insights (298)
  • Lifestyle and Wellness (21)
  • Medical Devices (24)
  • Pharmaceuticals (45)
  • Uncategorized (1)

Recent Posts

  • FDA Backs Proposed Stem Cell Trial for Treatment-Resistant Crohn’s Disease
  • Lasix ONYU Home Study: 18 of 21 Heart Failure Patients Avoided Admission
  • Castle Biosciences Data Show Barrett’s Risk Test Shifts Surveillance Plans
  • Envoy’s Fully Implanted Cochlear Implant Files Second FDA Module
  • Sun Pharma Board Caps Debenture Raise at ₹10,000 Crore

You May Have Missed

Canada Initiates First Clinical Trial of the Neuralink Brain Chip Implant to Revolutionize Neurological Care
  • Medical Devices

Canada Initiates First Clinical Trial of the Neuralink Brain Chip Implant to Revolutionize Neurological Care

Megan Wood 2 years ago2 years ago
Smart Healthcare Fabrics Market Revenue, Trends, and Strategic Insights by 2032
  • Industry Insights

Smart Healthcare Fabrics Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 9 months ago
Walking Assist Devices Market Revenue, Trends, and Strategic Insights by 2032
  • Industry Insights

Walking Assist Devices Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 5 months ago
Anti‑Obesity Drugs Market
  • Industry Insights

Anti‑Obesity Drugs Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 7 months ago
Graphic of WHO childhood obesity guidance: lifestyle only under 10, medicine considered at 10 to 19 after lifestyle care, surgery only in severe cases
  • Pharmaceuticals

Change Lifestyle Before Giving Children Weight-Loss Medication, WHO Says

Megan Wood 5 days ago4 days ago
Compound Management Market Revenue, Trends, and Strategic Insights by 2033
  • Industry Insights

Compound Management Market Revenue, Trends, and Strategic Insights by 2033

Megan Wood 9 months ago
Europe teeth cleaning machine market potential highlighting advanced oral care technology
  • Industry Insights

Europe Teeth Cleaning Machine Market Projected to Hit USD 1,006.1 Million by 2032, Growing at a 6.7% CAGR – Exclusive Report by Acumen Research and Consulting

Megan Wood 2 years ago2 years ago
Avascular Necrosis Market Revenue, Trends, and Strategic Insights by 2032
  • Industry Insights

Avascular Necrosis Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 5 months ago
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.